Therapy Areas: Hereditary Disorders
Sequenom announces MaterniT21 test study results
3 February 2012 - Sequenom Inc (NASDAQ:SQNM), a US-based diagnostic testing and genetics analysis company, said on Thursday that an independent study on Sequenom Centre for Molecular Medicine's M...
Shire, Sangamo join hands on haemophilia treatments
2 February 2012 - Irish Shire plc (LON:SHP) and US genome-editing technology specialist Sangamo BioSciences Inc (NASDAQ:SGMO) said on Wednesday they have signed a collaboration and licence deal to dev...
MDA allocates USD12m for neuromuscular disease research
2 February 2012 - The Muscular Dystrophy Association allocated over USD12m (EUR9.1m) to fund 38 research projects focused on the causes and potential treatments for various forms of neuromuscular dise...
FDA greenlights Vertex's cystic fibrosis drug KALYDECO
31 January 2012 - US Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) said on Tuesday that KALYDECO (ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF), has been app...
24 January 2012 - Genzyme Corp, a subsidiary of France's Sanofi SA (EPA:SAN), said on Tuesday that the US Food and Drug Administration (FDA) had given the green light for the launch of production...
FDA approves production of Fabrazyme at Genzyme's Framingham plant
24 January 2012 - Genzyme Corp, a subsidiary of France's Sanofi SA (EPA:SAN), said on Tuesday that the US Food and Drug Administration (FDA) had given the green light for the launch of production...